| Financial Year |
September 30 2019 |
| Monetary Funds |
2,507,090.64 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,248,538,060.06 |
| Advances to Suppliers |
1,656,996,354.30 |
| Other Receivables |
242,019,820.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,334,696,296.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
531,324,410.59 |
| Total Current Assets |
5,016,082,033.09 |
| Available-for-Sale Financial Asset |
177,839,733.14 |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
108,796,386.86 |
| Under-construction Projects |
17,508,117.54 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
107,589,906.32 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
12,320,199.33 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
41,166,026.00 |
| Sub-Total of Non-Current Assets |
465,220,369.19 |
| Total Assets |
5,481,302,402.28 |
| Short-Term Loans |
869,152,404.83 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,433,748,655.74 |
| Accounts Received In Advance |
47,119,133.66 |
| Employee Compensation Payable |
61,119,904.59 |
| Taxes Payable |
38,467,463.20 |
| Interest Payable |
180,550,353.36 |
| Dividend Payable |
-- |
| Other payables |
543,349,884.18 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,002,177,640.65 |
| Other Current Liabilities |
475,543,643.00 |
| Sub-Total of Current Liabilities |
4,470,678,729.85 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
87,735,178.10 |
| Special Payable |
-- |
| Estimatied Liabilities |
609,311,475.80 |
| Deferred Income Tax Liabilities |
4,233,024.18 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
704,287,829.59 |
| Total Liabilities |
5,174,966,559.44 |
| Paid-In Capital(Or Share Stock) |
1,010,024,415.00 |
| Capital Surplus |
351,075,602.53 |
| Surplus Reserve |
84,424,544.36 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,139,188,719.05 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
306,335,842.84 |
| Owner's Equity（Stockholder's Equity） |
306,335,842.84 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,481,302,402.28 |
